Search results
Bristol Myers Squibb Announces 10-Year Strategy to Reach More Patients in Low- and Middle-Income...
Morningstar· 2 days agoThe Company enters strategic collaboration with the Access to Oncology Medicines (ATOM) Coalition to expand access to immuno-oncology therapy Opdivo™ in select countries PRINCETON ...
Bristol Myers Squibb to Present Data at the 2024 American Society of Clinical Psychopharmacology...
Morningstar· 1 day agoBristol Myers Squibb to Present Data at the 2024 American Society of Clinical Psychopharmacology Annual Meeting Consistent with short-term studies, KarXT ...
Hawaii court orders drug companies to pay $916 million in Plavix blood thinner lawsuit - The Boston...
The Boston Globe· 2 days agoThe judgment was issued against Bristol Myers Squibb Company and three US-based subsidiaries of...
Cencora Provides Notice of Data Breach Affecting Bristol Myers Squibb Customers’ Information | JD...
JD Supra· 4 days agoIn this notice, Cencora explains that the incident...
Halozyme Announces Bristol Myers Squibb Received Updated Action Date from the U.S. Food and Drug...
Morningstar· 3 days agoUpdated Prescription Drug User Fee Act goal date of December 29, 2024 SAN DIEGO, May 21, 2024 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that < ...
Bristol Myers, Sanofi liability in Hawaii Plavix case grows to $916 million
Reuters· 2 days ago, opens new tab to pay more than $916 million to the state for failing to warn non-white patients of...
Pfizer to Cut Costs in Multi-Year Effort — Update
Morningstar· 2 days agoThe first phase is focused on operational efficiencies...filing Wednesday didn't state the number of expected job cuts, but the company said severance and implementation costs ...
... Positioned To Absorb Humira Biosimilar Erosion': Analyst - AbbVie (NYSE:ABBV), Bristol-Myers ...
Benzinga· 7 days agoCantor Fitzgerald initiates coverage on AbbVie with an Overweight rating and a $200 price target....
3 Attractive High Dividend Stocks Yielding Over 5%
TheStreet.com· 7 days agoAs a result, many stocks have lower dividend yields than they did several years ago, due to rising share prices. Truist Financial (TFC) is a financial...
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a...
CNBC· 1 day agoBig pharma is betting billions on an up-and-coming class of cancer treatments that some on Wall...
